Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia · Delayed Price · Currency is AUD 0.1850
+0.0150 (8.82%)
May 8, 2026, 4:10 PM AEST
ASX:PAR Market Cap
ASX:PAR has a market cap or net worth of 97.21 million as of May 8, 2026. Its market cap has decreased by -16.79% in one year.
Market Cap
97.21M
Enterprise Value
91.85M
Revenue
8.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
Market Cap Chart
Since August 19, 2015, ASX:PAR's market cap has increased from 32.40M to 97.21M, an increase of 199.99%. That is a compound annual growth rate of 10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 97.21M | -33.28% |
| Dec 31, 2025 | 145.70M | -0.23% |
| Dec 31, 2024 | 146.04M | -2.24% |
| Dec 29, 2023 | 149.39M | -62.33% |
| Dec 30, 2022 | 396.54M | -8.38% |
| Dec 31, 2021 | 432.81M | -25.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nyrada | 137.17M |
| Dimerix | 129.09M |
| Alterity Therapeutics | 119.63M |
| Island Pharmaceuticals | 104.31M |
| Arovella Therapeutics | 91.87M |
| Immutep | 88.42M |
| Cynata Therapeutics | 79.55M |
| LTR Pharma | 79.07M |